Work

Vardenafil, a clinically available phosphodiesterase inhibitor, potentiates the killing effect of EGCG on CLL cells

Year: 2014

Type: article

Abstract: role in the laboratory and assisted in analysing the data.GH helped to conceptualize the structure of the study.YZ contributed to the execution of the research.VJ helped with data analysis.As chief of the department, WH helped conceptualize the study and provided essential reagents or tools.MD acted in an advisory role, designed the research study and contributed essential reagents or tools.The 'Lymphoma Research Foundation' and the 'European Mantle Cell Lymphoma Network' supported this work.DH and MD have a patent pending on obinutuzumab combination treatment.WH and MD have received speaker's honoraria and support of investigatorinitiated trials from Roche and are members of the scientific advisory board for Roche.MW, GH, YZ, VJ declare no potential conflict of interest.We thank the 'Helmholtz Zentrum M€ unchen -German Research Centre for Environmental Health' for providing research facilities.We thank Dr.

Source: British Journal of Haematology

DOI: 10.1111/bjh.13135